Key Summary

A comprehensive guide for medical device manufacturers on preparing for renewal of overseas registration for rehabilitation devices, covering regulatory classification, documentation, common pitfalls, and a preparation checklist.

Key Summary

Before the expiration of an overseas registration certificate for rehabilitation devices, manufacturers should initiate renewal preparations 12–18 months in advance. The core task is not merely to submit a continuation application, but to re-confirm whether the product's regulatory classification, registration pathway, and applicable standards in the target country have changed. A systematic review should cover the technical documentation from the initial registration, quality management system certificates, clinical evaluation or evidence, labeling and instructions for use, and post-market surveillance data to determine which materials can be reused directly and which require localization under current regulations.

Common risks include overlooking local agent or authorized representative change requirements, failing to update ISO 13485 or MDSAP certificates, inadequate adverse event and after-sales surveillance records, label language and symbols not conforming to the latest standards, and failing to submit renewal applications according to each GHWP member country's specific requirements. It is recommended that manufacturers prioritize establishing a registration certificate expiry ledger, assess common technical documentation and difference lists for multi-country registrations, and confirm renewal processes, fees, and official review timelines with local agents in advance.

For rehabilitation devices that involve electrical safety, biocompatibility, and usability testing, special attention should be paid to whether additional testing is required after standard revisions and whether original test reports remain acceptable.

Applicable Scenarios and Core Issues

Common categories of rehabilitation devices in overseas markets include medium and low frequency therapeutic devices, shock wave therapy devices, ultrasound therapy equipment, rehabilitation training beds, joint range-of-motion training devices, wheelchairs, and walkers. Registration requirements vary across markets such as the EU, US, Southeast Asia, Middle East, and Latin America, with registration certificate validity typically ranging from 1 to 5 years. Renewal is not a simple form update after expiration; it is a re-confirmation of the product's compliance status. Many manufacturers overlook registration certificate validity management and only start preparations when products are detained by customs or reminded by a local agent.

The core issue is not whether application materials exist, but whether existing materials remain compliant. For example, the IEC 60601 series standards originally applied may have been revised, and the continued validity of original test reports must be assessed. The manufacturer must also verify whether product software versions, battery capacity, materials, or intended uses have changed, and whether local regulations have introduced new cybersecurity or usability requirements. These issues must be systematically investigated and incorporated into a renewal project plan.

Registration Judgment Logic

Step 1: Confirm Device Status

The first step is to determine whether the product still qualifies as a medical device in the target country. Some rehabilitation devices may be reclassified due to changes in classification rules; for example, mobility walkers may be medical devices, while certain sports recovery devices may fall into general health products and no longer require registration. Manufacturers should re-check local classification rules or use classification databases.

Step 2: Determine Risk Class

According to the target country's classification system, rehabilitation devices range from low to high risk (e.g., Class I, IIa, IIb, or Class II, III). The risk class directly affects the renewal pathway, technical documentation requirements, and review depth. Manufacturers should confirm whether the intended use, structural composition, or working principle has changed during the original registration validity period. If changes have occurred, a simple continuation may not be allowed; a variation filing or new registration may be required.

Step 3: Assess Reusability of Existing Evidence

Compare the technical files, test reports, and clinical evidence submitted during initial registration against current standards. Focus on whether new performance tests, biocompatibility tests, or usability tests are needed under revised standards. Also confirm that the quality management system certificate is valid and covers the current production address and product models.

Additionally, for GHWP member countries such as Thailand, Malaysia, and Vietnam, while registration dossiers from other countries may be referenced, each country still requires its own format and local agent. A country-specific difference list should be established, clarifying whether local testing, GMP audits, or acceptance of ISO 13485 as quality system evidence is required.

Materials and Evidence

Renewal application materials typically include the registration application form, copy of the original registration certificate, product technical documentation, quality management system certificates, declaration of conformity, post-market surveillance reports, adverse event reports, change records, and label/IFU samples. If evidence is derived from CE or FDA registration, confirm whether it satisfies local regulatory requirements for cited sources.

Rehabilitation devices often require evidence of electrical safety, electromagnetic compatibility, biocompatibility, performance testing, and usability evaluation. If original reports are more than five years old, some countries may require updated test summaries or retesting. In addition, labels and instructions must comply with local language, measurement units, and warning requirements. If the original label has been updated, the renewed version must be submitted simultaneously.

For GHWP member countries, including Thailand, Malaysia, Vietnam, Saudi Arabia, and Brazil, manufacturers should verify that the local registration agent or authorized representative is still valid and that the agent information on the product registration certificate is updated if necessary. Many countries also require free sales certificates or export certificates, which have validity periods and should be obtained in advance.

Because rehabilitation devices often contain electronic and mechanical components, many countries require product photographs, instructions for use, technical drawings, and a list of key components. Ensure these documents match the current production version and, when necessary, have designers and regulatory affairs teams jointly confirm. Updates to intended uses, contraindications, and warnings in the IFU must be submitted together.

Common Mistakes

  • Ignoring certificate validity and failing to establish a 12-month advance reminder mechanism, leading to rushed preparations.
  • Not performing a change assessment and submitting the original registration dossier as a continuation without reporting product changes, resulting in review rejection or additional information requests.
  • Not verifying whether original test reports remain acceptable, especially submitting reports based on old standards after standard revisions, causing review delays.
  • Allowing quality management system certificates to expire or failing to update production address changes, so registration cannot be matched with current system documents.
  • Overlooking local agent changes or contract expirations, making it impossible for the regulatory authority to contact the local responsible person and thus rejecting the submission.
  • Having incomplete post-market surveillance records without sufficient adverse event analysis and product traceability data, prompting requests for supplemental information.

Company Preparation Checklist

  • Establish a registration certificate expiry ledger listing all target countries' certificate numbers, validities, local agents, and required lead times.
  • Re-confirm the product's regulatory status and risk classification against the latest regulations and classification rules.
  • Inventory technical files, test reports, clinical evidence, and label versions from initial registration and any variations, creating a traceable document list.
  • Confirm that ISO 13485, MDSAP, or other quality management system certificates are valid and cover the current production address and product scope.
  • Confirm renewal service content, fees, and official timelines with local agents or authorized representatives, and obtain the latest application forms.
  • Prepare post-market surveillance documents, including adverse event reports, complaint records, annual updates, or periodic safety update reports.
  • Evaluate whether labels and instructions need updating and prepare target language versions.
  • For multi-country renewals, develop a plan for reusing common technical documents and preparing local difference supplements.

AIMEILI Insights

The most common misjudgment is that renewal is simply a form submission as long as the original registration certificate has not been revoked. In reality, most countries' renewal reviews will re-confirm whether the product still complies with current regulations and standards. If manufacturers fail to assess changes and standard revisions in advance, the time needed for supplementary testing and documentation will far exceed expectations.

In the early project phase, a gap analysis should be performed to compare existing technical documentation against the latest regulatory requirements of the target country. Do not wait until the renewal application window opens to begin preparation. Risk management reports, basic safety and performance test reports, and clinical evaluation conclusions can be reused, but labels, instructions for use, registration agent information, and post-market surveillance reports must be localized according to local requirements. Control of the certificate is a critical point: the registration certificate is often held by a local agent or certificate holder. If the manufacturer does not have access to the original certificate and update rights, renewal can become very passive. For multi-country registrations, it is advisable to first establish a unified technical document database and then perform incremental conversion based on each country's format and language requirements, significantly reducing duplicate work and review corrections.

We recommend designating a dedicated person responsible for registration certificate expiration management and establishing quarterly communication mechanisms with local agents. Do not wait for an official notice before initiating renewal. After submission, authorities may request additional information during review, so manufacturers should reserve a 3–6 month response window.

Common Follow-up Questions

Can a renewal application be submitted after the certificate expires?

Some countries allow submission within a certain grace period after expiration, but the product cannot be sold or imported during that period. Other countries do not accept late submissions and only allow complete re-registration. It is recommended to apply according to official deadlines and retain proof of submission.

Is it necessary to redo all tests when product standards are updated?

No. The impact should be assessed based on the specific changes in the new standard. Manufacturers may refer to the local regulatory authority's standard transition guidance or consult a notified body. If substantive changes involve electrical safety, electromagnetic compatibility, or usability, supplementary testing is usually required.

Can the same technical documentation be shared for multi-country renewals?

Underlying technical documents such as product descriptions, design verification, performance testing, and risk management reports can be shared, but attention must be paid to each country's requirements for format, language, clinical evidence, and agent information. Localized difference conversion is necessary. A risk-based technical document summary approach is recommended to improve reuse efficiency.

Source and Applicability

Source: Compiled from the AIMEILI Registration Practice Database, Medical Device International Registration Knowledge Base, and publicly available regulatory information. Specific projects should be based on the latest requirements of the target country's regulatory authorities and the product's documentation basis.

Source and Language Notice

View Chinese original page

Related Reading

Need a registration pathway assessment?

Send product type, intended use, target countries and existing certificates. AIMEILI can help evaluate registration pathway, documentation gaps and compliance risks.

Contact AIMEILI